Stay updated on Maintenance Study Rovalpituzumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Maintenance Study Rovalpituzumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Maintenance Study Rovalpituzumab in Small Cell Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 in the page footer, reflecting a minor site update.SummaryDifference0.1%

- Check18 days agoChange DetectedThe Record History now includes Revision: v3.4.1. The notice about government funding and Revision: v3.4.0 have been removed from the history.SummaryDifference0.5%

- Check25 days agoChange DetectedA site-wide notice banner was added indicating that information on the site may not be up to date due to a lapse in government funding, and that the NIH Clinical Center is open with links to cc.nih.gov and opm.gov for status updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check32 days agoChange DetectedUI/documentation updates: glossary visibility and color-coded highlights for additions and deletions were described, and the revision label updated to v3.4.0. The No FEAR Act data note capitalization was adjusted.SummaryDifference0.6%

- Check39 days agoChange DetectedRevision: v3.3.4 is now listed as the latest update, replacing v3.3.3; no study data or record content has changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision v3.3.3 has been added to the study history, reflecting an update to the record. The HHS Vulnerability Disclosure entry and Revision v3.3.2 were removed from the history.SummaryDifference0.1%

Stay in the know with updates to Maintenance Study Rovalpituzumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Maintenance Study Rovalpituzumab in Small Cell Lung Cancer Clinical Trial page.